CR9854A - Procesos para la sintesis de los compuestos para inhibicion de selectina - Google Patents

Procesos para la sintesis de los compuestos para inhibicion de selectina

Info

Publication number
CR9854A
CR9854A CR9854A CR9854A CR9854A CR 9854 A CR9854 A CR 9854A CR 9854 A CR9854 A CR 9854A CR 9854 A CR9854 A CR 9854A CR 9854 A CR9854 A CR 9854A
Authority
CR
Costa Rica
Prior art keywords
compounds
synthesis
processes
selectin
selectin inhibition
Prior art date
Application number
CR9854A
Other languages
English (en)
Inventor
Youchu Wang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9854A publication Critical patent/CR9854A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las presentes ensenanzas se relacionan con el campo de sustancias antiinflamatorias, y mas particularmente con la prepracion de los compuestos que actuan como antagonistas de las proteinas de adhesion de mamiferos conocidas como selectinas . En algunas modalidades, las actuales ensenanzas proporcionan metodos para preparar compuestos para tratar trastornos mediados por selectina que tienen la formula VI: en donde R1, R2, R3,p, y q se definen aqui.
CR9854A 2005-10-05 2008-04-01 Procesos para la sintesis de los compuestos para inhibicion de selectina CR9854A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72373405P 2005-10-05 2005-10-05

Publications (1)

Publication Number Publication Date
CR9854A true CR9854A (es) 2008-05-21

Family

ID=37672216

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9854A CR9854A (es) 2005-10-05 2008-04-01 Procesos para la sintesis de los compuestos para inhibicion de selectina

Country Status (19)

Country Link
US (1) US20070082923A1 (es)
EP (1) EP1931638A1 (es)
JP (1) JP2009511488A (es)
KR (1) KR20080053389A (es)
CN (1) CN101277936A (es)
AR (1) AR058079A1 (es)
AU (1) AU2006302375A1 (es)
BR (1) BRPI0616906A2 (es)
CA (1) CA2624552A1 (es)
CR (1) CR9854A (es)
EC (1) ECSP088340A (es)
GT (1) GT200600447A (es)
IL (1) IL190435A0 (es)
NO (1) NO20081548L (es)
PE (1) PE20070590A1 (es)
RU (1) RU2008112191A (es)
TW (1) TW200738639A (es)
WO (1) WO2007044475A1 (es)
ZA (1) ZA200802990B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090127183A (ko) * 2007-03-30 2009-12-09 와이어쓰 퀴놀린 유도체, 및 이를 포함하는 셀렉틴 억제용 제약 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239280B1 (en) * 1999-06-30 2001-05-29 Merck & Co., Inc. Process for synthesizing biaryl inhibitors of farnesyl-protein transferase
PA8616901A1 (es) * 2003-11-10 2005-05-24 Wyeth Corp Metodos y composiciones para la inhibicion de selectina

Also Published As

Publication number Publication date
TW200738639A (en) 2007-10-16
ZA200802990B (en) 2008-12-31
BRPI0616906A2 (pt) 2011-07-05
AR058079A1 (es) 2008-01-23
NO20081548L (no) 2008-04-28
CA2624552A1 (en) 2007-04-19
WO2007044475A1 (en) 2007-04-19
ECSP088340A (es) 2008-06-30
CN101277936A (zh) 2008-10-01
AU2006302375A1 (en) 2007-04-19
JP2009511488A (ja) 2009-03-19
IL190435A0 (en) 2008-11-03
EP1931638A1 (en) 2008-06-18
GT200600447A (es) 2007-05-08
US20070082923A1 (en) 2007-04-12
KR20080053389A (ko) 2008-06-12
RU2008112191A (ru) 2009-11-10
PE20070590A1 (es) 2007-07-11

Similar Documents

Publication Publication Date Title
GT200600346A (es) Nueva fórmula cristalina v de la agomelatina, un proceso para su preparación y composiciones farmacéuticas que la contienen
UY30500A1 (es) Compuestos de azabencimidazolilo
DOP2011000237A (es) Inhibidores de poli (adp-ribosa) polimerasa (parp)
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
CL2015002635A1 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
ECSP12012326A (es) Derivados de aminopirimidina como moduladores de la lrrk2
CO6450612A2 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
CO6950483A2 (es) 5,7-imidazo[1,2-c]pirimidinas sustituidas
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
UY30141A1 (es) Nuevas isoindolonas potenciadoras de receptores metabotropicos de glutamato
ECSP066557A (es) Métodos y composiciones para inhibición de selectina
UY31870A (es) Receptor metabotrópico de glutamato potenciadores 286
UY29339A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
AR070907A1 (es) Formas cristalinas de derivado de nitrocatecol
CL2007001711A1 (es) Compuestos derivados de pirazolopiridina sustituida;composicion farmaceutica que los comprende;metodo de preparacion de los compuestos ,compuestos intermediarios;y su uso en el tratamiento de enfermedades,tales como tumores,artritis reumatoide,enfermedades del crecimiento vascular desregulado, entre otras.
UY32383A (es) Dionas cíclicas herbicidamente activas, derivados, procesos para su preparación composiciones que las comprenden y usos de las mismas
CR8384A (es) Metodos y composiciones para la inhibicion de selectina
EA201100921A1 (ru) Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
NI201100096A (es) Lactamas como inhibidores de beta secretasa.
UY33415A (es) Composiciones de alcoxicarboxamidas microbiocidas y fungicidas y su preparacion
ECSP11011217A (es) Microbiocidas nuevos.
UY28911A1 (es) Profármacos de esteroides con acción androgénica
UY29481A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)